{
  "retracted": false,
  "timestamp": 1303430400000,
  "updates": [
    {
      "timestamp": 1581973830709,
      "identifier": {
        "doi": "10.1245/s10434-011-1681-8"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1245/s10434-010-1401-9"
  },
  "journal": "Annals of Surgical Oncology",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer"
}
